Login / Signup
Meiqi Li
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Poor Prognosis
Gene Expression
Drug Delivery
Dna Methylation
Top Venues
Cancer research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Yongheng Chen
,
Ying Ying
,
Wenlong Ma
,
Hongchao Ma
,
Liang Shi
,
Xuefeng Gao
,
Min Jia
,
Meiqi Li
,
Xiaoman Song
,
Weixiao Kong
,
Wei Chen
,
Xiangyi Zheng
,
Tobias Achu Muluh
,
Xiaobin Wang
,
Maolin Wang
,
Xing-Sheng Shu
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
Cancer research
84 (8) (2024)
Yongheng Chen
,
Ying Ying
,
Wenlong Ma
,
Hongchao Ma
,
Liang Shi
,
Xuefeng Gao
,
Min Jia
,
Meiqi Li
,
Xiaoman Song
,
Weixiao Kong
,
Wei Chen
,
Xiangyi Zheng
,
Tobias Achu Muluh
,
Xiaobin Wang
,
Maolin Wang
,
Xing-Sheng Shu
Targeting the epigenetic reader ENL inhibits super-enhancer-driven oncogenic transcription and synergizes with BET inhibition to suppress tumor progression.
Cancer research
(2024)
Yongheng Chen
,
Ying Ying
,
Wenlong Ma
,
Hongchao Ma
,
Liang Shi
,
Xuefeng Gao
,
Min Jia
,
Meiqi Li
,
Xiaoman Song
,
Weixiao Kong
,
Wei Chen
,
Xiangyi Zheng
,
Tobias Achu Muluh
,
Xiaobin Wang
,
Maolin Wang
,
Xing-Sheng Shu
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression.
Cancer research
84 (8) (2024)